All News

vasculitis.Churg-Strauss_syndrome.wikipedia.jpg

Serious Infections Still Common in Vasculitis

Save

d MedPage Today

Mar 29, 2021

Serious infections occurred more frequently among patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis who were given induction therapy with cyclophosphamide compared with rituximab (Rituxan), Greek researchers found.

Read Article

RheumNow Podcast – Infection in ANCA-Associated Vasculitis (3.26.2021)

Save

d Jack Cush, MD

Mar 26, 2021

Dr. Jack Cush reviews the news, FDA Denials and journal articles from the past week on RheumNow.com.

Read Article

Takeaways from #RNL2021 from Dr. Rachel Tate ( @uptoTate ) "Severe flares in PsO pts previously well controlled: look for infection (HIV or other) and/or underlying malignancy. Melodie Young, NP #RNL2021" #RheumNow

Dr. John Cush RheumNow ( View Tweet)

Mar 29, 2021

Listen to our latest QD clinic--Why Pain Consults present Not Taking Pain Meds https://t.co/75YO027Oh6 https://t.co/QrbiBnGbGd

Links:

https://buff.ly/3fekGmk

Dr. John Cush RheumNow ( View Tweet)

Mar 29, 2021

The Reflecting Rheum: 2020 SpA and Still’s Disease Highlights Sponsored by Novartis Medical Affairs Listen to a discussion of medical experts share their views on the most impactful work done in spondyloarthritis and Still’s disease in 2020. https://t.co/Kp2drDAqFv https://t.co/6oOGSq0Psl

Links:

https://buff.ly/3tHTsbA

Dr. John Cush RheumNow ( View Tweet)

Mar 29, 2021

QD147 Pain, but No Pain Meds QD Clinic - Lessons from the clinic Why Pain Consults present Not Taking Pain Meds Features Dr. Jack Cush https://t.co/yRNh6QraED

Links:

https://buff.ly/3u0RumP

Dr. John Cush RheumNow ( View Tweet)

Mar 28, 2021

Potent Topical Corticosteroids and the Risk of Osteoporotic Fractures https://t.co/OHohMKveik

Links:

https://buff.ly/3sxCcWa

Dr. John Cush RheumNow ( View Tweet)

Mar 28, 2021

#RNL2021 Thanks @uptoTate https://t.co/VKFodPOwgC

Links:

https://twitter.com/uptotate/status/1373355508644642819

Dr. John Cush RheumNow ( View Tweet)

Mar 28, 2021

#RNL2021 coverage by @uptoTate for #RheumNow https://t.co/x1GjGGNPii

Links:

https://twitter.com/uptotate/status/1373355123620077576

Dr. John Cush RheumNow ( View Tweet)

Mar 27, 2021

Great #RNL2021 coverage by @KDAO2011 for #RheumNow https://t.co/GBnlyvPaz1

Links:

https://twitter.com/kdao2011/status/1373279374225588231

Dr. John Cush RheumNow ( View Tweet)

Mar 27, 2021

Liver Management in RA - #RNL2021 Highlight by @DrPetryna While RA is not known to affect the liver directly, underlying liver disease and treatment-related effects on the liver can often become an obstacle in the mgmt of many RA patients. https://t.co/OeuloDIXMF

Links:

https://buff.ly/3cbpHtG

Dr. John Cush RheumNow ( View Tweet)

Mar 27, 2021

New RheumNow Podcast Now Available! Infection in ANCA-Associated Vasculitis https://t.co/Twy04G9RU1 Download wherever podcasts are available!

Links:

https://buff.ly/3fjQBlo

Dr. John Cush RheumNow ( View Tweet)

Mar 27, 2021

RheumNow Podcast – Infection in ANCA-Associated Vasculitis Dr. Jack Cush reviews the news, FDA Denials and journal articles from the past week on https://t.co/4GKxMY5Lll https://t.co/joi1puBSuX

Links:

Dr. John Cush RheumNow ( View Tweet)

Mar 26, 2021

#RNL2021 coverage from @KDAO2011 #RheumNow https://t.co/GBnlyvPaz1

Links:

https://twitter.com/kdao2011/status/1373279374225588231

Dr. John Cush RheumNow ( View Tweet)

Mar 26, 2021

Are You a Super Rheum? https://t.co/omvQXwhcoV https://t.co/8iQaRAi5di

Links:

https://buff.ly/3cp3B7j

Dr. John Cush RheumNow ( View Tweet)

Mar 26, 2021

Analysis of CPRD registry and 15670 MTX treated pts (46,571 PYs) showed discontinuation for abnormal or severely abnormal labs was 42/1000PY and 6/1,000PY; half that after Yr 1 (22 & 2.84). D/C for severe labs was 1 in 169 Yr1 & 1 in 352 per year after https://t.co/Dx91YqjplT

Links:

https://buff.ly/39hCyJ7

Dr. John Cush RheumNow ( View Tweet)

Mar 26, 2021

#RNL2021 Highlights: Future Therapeutics for Rheumatoid Arthritis and Lessons Learned https://t.co/NxLyHeI2f4 https://t.co/df7lPEia0D

Links:

https://buff.ly/3rmIQxk

Dr. John Cush RheumNow ( View Tweet)

Mar 26, 2021

News Feature: FDA Panel Rejects Tanezumab for Osteoarthritis A 2 day FDA review by the Drug Safety and Risk Management and Arthritis Advisory Committees has yielded a 19-1 vote against the approval of tanezumab for use in OA. https://t.co/ltKmm9Nl1y https://t.co/qTWhSX9LBd

Links:

https://buff.ly/3tOxJii

Dr. John Cush RheumNow ( View Tweet)

Mar 26, 2021

The Reflecting Rheum: Top Publications from 2020 Covering SpA and Still’s Disease Sponsored by Novartis Medical Affairs Listen to a panel of experts share their views on top spondyloarthritis and Still’s disease publications from 2020. View Now: https://t.co/Kp2drDAqFv https://t.co/tjkUpxcMdT

Links: